• Boys With Undescended Testicles at Higher Risk for Testicular Cancer Study

    Updated: 2012-11-29 21:19:45
    : Health News Boys With Undescended Testicles at Higher Risk for Testicular Cancer : Study Print E-mail THURSDAY , Nov . 29 HealthDay News Boys whose testes have not descended at birth have an increased risk of developing testicular cancer later in life , a new study . says The findings raise the question of whether these boys should be regularly monitored to lower their potential risk for testicular cancer , the researchers . said When testes fail to descend into the scrotum and remain in the abdomen , the condition is called cryptorchidism . It's the most common birth defect in boys and affects about 6 percent of newborn . males Researchers analyzed 12 studies published between 1980 and 2010 that examined the link between cryptorchidism and testicular cancer . Based on the collective

  • Thyroid Cancer Drug Gets FDA OK

    Updated: 2012-11-29 21:17:35
    SILVER SPRING, Md. -- The FDA has approved cabozantinib (Cometriq) for metastatic medullary thyroid cancer, even though the drug did not prolong overall survival in clinical trials.

  • Aspirin May Reduce Risk of Liver Cancer Death From Liver Disease

    Updated: 2012-11-29 03:53:16
    , Health News Aspirin May Reduce Risk of Liver Cancer , Death From Liver Disease Print E-mail WEDNESDAY , Nov . 28 HealthDay News Aspirin use seems to be associated with a decreased risk of liver cancer and death from chronic liver disease , according to a large new . study This new study included more than 300,000 people aged 50 to 71, who reported their aspirin and nonsteroidal anti-inflammatory drug NSAID use and were followed for 10 to 12 years . During that time , more than 400 participants died from chronic liver disease and 250 were diagnosed with liver . cancer Compared to people who didn't take NSAIDs , people who took aspirin were 45 percent less likely to die from chronic liver disease and 41 percent less likely to be diagnosed with liver cancer . People who took non-aspirin

  • Managing Nausea & Increasing Appetite During Treatment – It’s Important

    Updated: 2012-11-28 20:02:10
    A very common side effect of any cancer treatment including chemotherapy (docetaxil for men with advanced prostate cancer) and radiation is nausea. In addition to feelings of nausea many men also experience a feeling of fullness, a change in the way foods taste and strong heartburn. If you have this experience let your doctor know [...]

  • New DNA-Based Blood Test May Spot Signs of Cancer

    Updated: 2012-11-28 19:52:01
    Health News New DNA-Based Blood Test May Spot Signs of Cancer Print E-mail WEDNESDAY , Nov . 28 HealthDay News A new study raises the possibility of a DNA-based blood test that doctors could routinely use to determine whether a patient has . cancer There are many caveats . The research is preliminary , and the test is not cheap . Even if it does detect cancer , the test like the one currently used to detect prostate cancer could raise big questions about how to deal with the . results Even so , a genetic test for cancer would be a major advance , experts . say This would be a way of detecting cancers earlier , and to tell you the level of cancer as you're going through the therapy , said Dr . Victor Velculescu , co-director of the Cancer Biology Program at Johns Hopkins Kimmel Cancer

  • Scientific breakthroughs from one small island could change the world

    Updated: 2012-11-28 18:00:00
    Game-changing medical advances are within our reach but this 'one small island' needs huge investment in science in order to make this a reality, author Bill Bryson will say tonight at the first Create The Change science lecture for Cancer Research UK.

  • Most Women Who Choose Double Mastectomy Don't Need To Study Shows

    Updated: 2012-11-28 03:50:49
    , Health News Most Women Who Choose Double Mastectomy Don't Need To , Study Shows Print E-mail TUESDAY , Nov . 27 HealthDay News Almost 70 percent of women with breast cancer who choose to have both breasts removed as a precaution actually have a low risk of developing cancer in the healthy breast , a new study . finds Worry about recurrence which is understandable typically drives the decision to have the opposite breast removed , said study author Dr . Sarah Hawley , an associate professor of internal medicine at the University of Michigan Health System in Ann Arbor . The procedure is called a contralateral prophylactic mastectomy CPM However , that worry can be out of proportion to actual risk , she said . Our point is that worry about recurrence probably should not drive choice for CPM

  • Cancer Research UK and Lorus to co-develop first-of-kind drug, IL-17E, to treat solid tumours

    Updated: 2012-11-27 15:30:00
    Cancer Research UK’s Drug Development Office; Cancer Research Technology, the charity's commercial arm; and biopharmaceutical company, Lorus Therapeutics Inc., have partnered to take a new therapy with the potential to treat solid tumours, into its first clinical trial.

  • Small study finds physical evidence for 'chemo brain'

    Updated: 2012-11-27 11:04:00
    Chemotherapy can trigger measurable physical changes in brain function linked with memory loss and lapses in concentration, a small study from the US suggests.

  • Stat5 as a Potential Biomarker for a Prostate Cancer Recurrence Post Surgery

    Updated: 2012-11-27 04:19:27
    Once you have had primary treatment for prostate cancer you must continue to actively monitor your PSA until you die. There is no cure; at least you should never assume that you have been cured because 1/3 of all men who have treatment will have a recurrence. What treatment you have does not matter, statistically [...]

  • Friendly nudge prompts 40 per cent to visit GP

    Updated: 2012-11-27 00:01:00
    More than a third (40 per cent) of people say talking to a friend or relative about a change to their body that was playing on their mind encouraged them to make an appointment with a GP, according to a new survey from Cancer Research UK.

  • 'Significant' new cancer drug resistance mechanism identified

    Updated: 2012-11-26 10:34:00
    A key cause of drug resistance in cancer cells has been identified by European and US researchers.

  • Do We Now Need To Question the Research Published in the NEJM?

    Updated: 2012-11-25 04:11:16
    A very interesting article appeared in the Saturday, November 24, 2012 edition of the Washington Post. According to the article The New England Journal of Medicine which is among the most prestigious medical journal in the world regularly features articles over which pharmaceutical companies and their employees exert significant influence. The problem is simple, over [...]

  • Muscle Building May Help Teens Avoid Early Death

    Updated: 2012-11-24 20:00:00
    Adolescents with high muscular strength had a lower risk of a premature death by age 55 or younger, researchers found.

  • Tobacco industry claims on cigarette packaging are nonsense

    Updated: 2012-11-23 00:01:00
    Claims that replacing alluring designs on cigarette packs with a plain standardised look will increase illegal tobacco production are baseless - according to a new report published today (Friday) by an international expert.

  • Emergency cancer care 'must improve'

    Updated: 2012-11-21 13:05:00
    More must be done to improve emergency care for people with cancer, according to a new joint report from The Royal College of Physicians and The Royal College of Radiologists

  • ADT and Estradiol Therapy Modify Memory in Men being Treated for Prostate Cancer

    Updated: 2012-11-20 16:08:13
    I just cannot remember where I put my keys. What is my home telephone number? What is his name, you know the guy I sit next to everyday in the office? Sound familiar, maybe because you are on hormone deprivation therapy (ADT) to treat your advanced prostate cancer. This can explain why your normally intact [...]

  • Death rates from ovarian cancer have fallen by 20 per cent over last decade

    Updated: 2012-11-20 00:01:00
    The rates of women dying from ovarian cancer in England have fallen from 11.2 women in every 100,000 (3,820 cases) in 2001 to 8.8 per 100,000 (3,453 cases) in 2010 – a drop of around 20 per cent, according to a new report by the National Cancer Intelligence Network published, today.

  • CapSure Showed the Association of Statin and Nonsteroidal Anti-inflammatory Drug use with Prostate Cancer All Cause Survival

    Updated: 2012-11-19 20:09:47
    In the prostate cancer world we often discuss treatment options, some approved by the FDA and some not approved. Among the treatment options bantered about are statins (3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor) and nonsteroidal anti-inflammatory drugs (NSAIDs). According to the folklore both these drugs are associated with reducing the risk of prostate cancer and improved [...]

  • Now an Early Access Site for Alpharadin Opens in New York

    Updated: 2012-11-18 15:50:10
    The Early Access Committee on which Malecare sits has been successful in adding an additional site in Long Island, New York to the Early Access Trial of Radium-233 Chloride (Alpharadin) for men with advanced prostate cancer who are castrate resistant and have at least two (2) bone metastases. If you are interested in this trial [...]

  • Xtandi Today & Tomorrow

    Updated: 2012-11-16 19:55:38
    Medivation, the pharmaceutical company that owns Xtandi (formerly known as MDV-3100), the new androgen receptor antagonist to treat castrate resistant advanced prostate cancer has a number of active clinical trials, despite the fact that it has already been approved for use. The current FDA approval is specific; it has been approved for men who are [...]

  • International agreements tackle tobacco smuggling and premature deaths

    Updated: 2012-11-16 16:47:00
    Two new international agreements are aiming to tackle the illegal tobacco trade and sharply reduce the number of people dying prematurely as a result of non-infectious diseases such as heart disease, cancer and strokes.

  • Radium-223 (Alpharadin) Improves Survival in Men with Metastatic Prostate Cancer

    Updated: 2012-11-15 18:40:29
    At the October 28 meeting of the American Society for Radiation the final data from the ALSYMPCA trial were presented. The trial evaluated radium-223 (Alpharadin) in men with castrate-resistant prostate cancer that had spread to the bones. Alpharadin is part of a class of drugs called alpha-particle emitters that targets bone metastases. The good news [...]

  • Top 10 Things Women Should Know About Prostate Cancer

    Updated: 2012-11-15 17:36:18
    Prostate cancer continues to be the second-leading cause of cancer death in men, with over 230,000 men diagnosed with prostate cancer each year. When someone is diagnosed with prostate cancer, the effects of the disease often reach to friends and family, particularly a wife or partner. The diagnosis, treatment and side effects of prostate cancer affect the surrounding family as [...] No related posts.

  • Drug approval process in Scotland under review

    Updated: 2012-11-15 16:48:00
    The decision-making process at NHS Scotland's drugs approval body is to be reviewed, following concerns about the inconsistent availability of certain medicines.

  • Review confirms exercise can help reduce cancer-related fatigue

    Updated: 2012-11-14 00:05:00
    Aerobic exercise like running, cycling or swimming can help alleviate the fatigue during or following cancer treatment, a new research review has confirmed.

  • More than 33,000 childhood cancer survivors living in the UK

    Updated: 2012-11-14 00:01:00
    An estimated 33,000 long-term survivors of childhood cancer - the vast majority of whom are cured - will be living in the UK by the end of 2012, according to new figures from Cancer Research UK.

  • Motivational text messages can help smokers quit

    Updated: 2012-11-14 00:01:00
    Smokers can be helped to quit by receiving motivational texts or video messages, according to a review of previous research studies.

  • So, Where Is Your Evidence – Is Our Propensity to Believe the Folk Law Wasting our Time & Money

    Updated: 2012-11-13 15:01:22
    Having hot flashes because of hormone deprivation therapy (ADT)? All of us dealing with advanced prostate cancer will be on ADT, it is the usual first line of therapy and it will continue until we die. Men who elect to have radiation to treat prostate cancer as their primary treatment modality will often have some [...]

  • Closing inequality gap could mean earlier diagnosis for thousands of people

    Updated: 2012-11-13 00:52:00
    Each year 5,600 patients are diagnosed with cancer at a late stage because of social and health inequalities, according to a new UK study.

  • AHA: HF Tied to Higher Risk for Fatal Cancer

    Updated: 2012-11-10 14:00:00
    LOS ANGELES -- Patients who developed heart failure had a 68% increased risk of cancer, which was associated with a 56% increased risk of death, researchers reported here.

  • Smart drug improves survival in older patients with acute myeloid leukaemia

    Updated: 2012-11-10 00:01:00
    Acute Myeloid Leukaemia (AML) patients given a new type of 'smart drug' in addition to chemotherapy treatment are 22 per cent less likely to relapse and around 13 per cent less likely to die from their disease, results from a major phase III Cancer Research UK-funded trial led by Cardiff University show today (Saturday).

  • How Much Does that Drug Cost? You Have to be Kidding!

    Updated: 2012-11-09 15:07:27
    How much money is a drug worth and how much money should we be willing to spend for it have been questions that have been increasingly asked by economists, doctors and cancer survivors. Last month in an Op-Ed article three doctors from Memorial Sloane Kettering Cancer Center in New York (Sloane) let the world know [...]

  • Anti-cholesterol drugs may prevent cancer deaths

    Updated: 2012-11-09 11:49:00
    Statins - a type of drug taken by millions in the UK to lower their cholesterol levels - may have an impact on cancer death rates, according to a new Danish study.

  • Lung cancer UK price tag eclipses the cost of any other cancer

    Updated: 2012-11-07 00:01:00
    The cost of lung cancer to the UK economy is £2.4 billion each year, far higher than the cost of any other cancer. This highlights the urgent need to continue to reduce the number of young people who become addicted to tobacco – as smoking causes more than eight in 10 lung cancers in the UK.

  • Smokers leave a history of their addiction in DNA

    Updated: 2012-11-06 00:01:00
    Smokers are leaving a history of addiction in their DNA that may help to measure their risk of cancer, according to research presented at the NCRI Cancer Conference today.

  • Three-in-one 'supermolecule' could detect cancer early, help destroy tumours and monitor treatment

    Updated: 2012-11-06 00:01:00
    The same protein could potentially be targeted to detect precancerous breast cells; deliver radiotherapy to destroy tumours; and monitor the effectiveness of treatment, according to a Cancer Research UK study presented at the NCRI Cancer Conference in Liverpool today.

  • Personalised prostate cancer screening may save thousands from unnecessary treatment

    Updated: 2012-11-05 00:01:00
    Targeting prostate cancer screening based on a man's age and genes could potentially save thousands of men from unnecessary treatment and save the NHS millions of pounds.

  • First figures help set the standard for gynaecological cancer surgery

    Updated: 2012-11-05 00:01:00
    The first UK multicentre figures showing that one in five women having major gynaecological cancer surgery have some sort of complication will help set standards in the NHS, according to research presented at the NCRI Cancer Conference today.

  • Bowel screening helps to detect early cancers before they have the power to kill

    Updated: 2012-11-04 00:00:00
    Bowel screening is detecting more cancers when they are less mature and have less aggressive biological characteristics according to new research presented at the NCRI Cancer Conference in Liverpool this week.

  • Viagra 'Rehab' Works for Prostate Cancer

    Updated: 2012-11-03 15:00:00
    BOSTON -- Prostate cancer patients reported significantly better sexual function after radiation therapy when they took sildenafil daily during and after treatment, results of a randomized trial showed.

  • HPV test for oral cancers may improve patient outcomes and treatments

    Updated: 2012-11-03 00:01:00
    A new test designed to classify tonsil and throat cancers into one of two groups should help deliver the right treatment to the right patients, according to research being presented at the NCRI Cancer Conference in Liverpool next week.

Current Feed Items | Previous Months Items

Oct 2012 | Sep 2012 | Aug 2012 | Jul 2012 | Jun 2012 | May 2012